Global weakness | Present (n = 5) | Absent (n = 16) | p value |
---|---|---|---|
Age - mean (SD) years | 7.3(2) | 10.5(3.3) | 0.04 |
CRP - mean (SD) mg/l | 52(81) | 4(4.5) | 0.03 |
ESR - mean (SD) mm/hr | 83(41) | 24(25) | 0.007 |
Contractures | Present (n = 8) | Absent (n = 13) | |
Age - mean (SD) years | 6.8(3) | 11.6(2) | 0.0003 |
CRP - mean (SD) mg/l | 45(75) | 3.8(3.9) | 0.000 |
ESR - mean (SD) mm/hr | 59(48) | 25(26) | 0.04 |
Calcinosis | Present (n = 15) | Absent (n = 6) | |
Age-mean (SD) years | 9.1(3.5) | 11.3(2) | 0.18 |
Duration of follow-up - mean (SD) (months) | 39 (28) | 13(14) | 0.04 |
CK - mean (SD) IU/l | 288 (402) | 2414(3201) | 0.02 |
Aldolase mean (SD) IU/ | 18.5 (12.6) | 38.6(23.5) | 0.03 |
Vasculitis (%) | 11(73.3) | 0 (0) | 0.003 |
Staphylococcus aureus infection (%) | 7 (46,7) | 0 (0) | 0.04 |
Staphylococcus aureus infection | Present (n = 7) | Absent (n = 14) | |
Duration of follow-up - mean (SD) (months) | 51(32) | 22(20) | 0.02 |